Frank Rimerman Advisors’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$377K Buy
10,455
+3,863
+59% +$139K 0.03% 399
2025
Q1
$205K Buy
+6,592
New +$205K 0.02% 496